FIRST CHINA PHARMACEUTICAL GROUP, INC. - FORM 10-Q - EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - May 18, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - FIRST CHINA PHARMACEUTICAL GROUP, INC.Financial_Report.xls
10-Q - QUARTERLY REPORT - FIRST CHINA PHARMACEUTICAL GROUP, INC.form10q.htm
EX-10.2 - FORM OF NOTE RECEIVABLE - FIRST CHINA PHARMACEUTICAL GROUP, INC.exhibit10-2.htm
EX-10.1 - PROMISSORY NOTE WITH BELMONT GROUP, LTD. - FIRST CHINA PHARMACEUTICAL GROUP, INC.exhibit10-1.htm
EX-32.2 - CERTIFICATION OF PRINCIPAL FINANCIAL AND PRINCIPAL ACCOUNTING OFFICER - FIRST CHINA PHARMACEUTICAL GROUP, INC.exhibit32-2.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - FIRST CHINA PHARMACEUTICAL GROUP, INC.exhibit31-1.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER AND PRINCIPAL ACCOUNTING OFFICER - FIRST CHINA PHARMACEUTICAL GROUP, INC.exhibit31-2.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of First China Pharmaceutical Group, Inc. (the “Company”) on Form 10-Q for the quarterly period ended March 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Zhen Jiang Wang, Chief Executive Officer of the Company, certify, to the best of my knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

  i.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

     
  ii.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 18, 2012

 

/s/ Zhen Jiang Wang  
Name: Zhen Jiang Wang  
Title: Chief Executive Officer (Principal Executive Officer)  

FIRST CHINA PHARMACEUTICAL GROUP, INC. Reports